IrsiCaixa develops antibodies that block one of the internalization pathways of the Ebola virus into human cells

by IrsiCaixa

The study demonstrates that the receptor Siglec-1 is used by different virus, such as Ebola, Marburg and HIV, to enter the myeloid cells and develops novel antibodies against this protein.

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Administrar zinc a los pacientes con COV...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Administrar zinc a los pacientes con COVID-19 podría ayudar a su recu...

Photos Stream